New treatments: Costs, benefits and decision-making procedures
| dc.contributor.author | Benatar, S R | |
| dc.contributor.author | Fleischer, T E | |
| dc.date.accessioned | 2016-01-05T07:23:56Z | |
| dc.date.available | 2016-01-05T07:23:56Z | |
| dc.date.issued | 2003 | |
| dc.date.updated | 2015-12-21T12:17:09Z | |
| dc.description.abstract | One hallmark of modern medicine is the ever-rising cost of providing life-saving or life-extending treatments. Advances in medical care and the ability to improve the duration and quality of life, combined with the expectations of both doctors and patients that all new modalities of treatment developed will be implemented in everyday practice, are the major reasons for modern medicine’s becoming so expensive. In these circumstances resource allocation decisions need to be made and appropriate priority-setting processes developed. This challenge faces all societies but most agonisingly middle income countries like South Africa where the expectations of physicians and patients are geared to the best that can be achieved in any country — even the wealthiest. Expensive, new or established standard treatments that may benefit patients may be considered in at least two categories. The first is when each individual patient will be a direct beneficiary. This applies, for example, when a pacemaker or orthopaedic prosthesis is installed, when an organ such as a kidney, heart or liver is transplanted, or when chronic renal dialysis is initiated. While such treatments have some mortality and a measure of sub-optimal results, good outcomes are the rule | en_ZA |
| dc.identifier.apacitation | Benatar, S. R., & Fleischer, T. E. (2003). New treatments: Costs, benefits and decision-making procedures. <i>South African Medical Journal</i>, http://hdl.handle.net/11427/16211 | en_ZA |
| dc.identifier.chicagocitation | Benatar, S R, and T E Fleischer "New treatments: Costs, benefits and decision-making procedures." <i>South African Medical Journal</i> (2003) http://hdl.handle.net/11427/16211 | en_ZA |
| dc.identifier.citation | Benatar, S. R., & Fleischer, T. E. (2003). New treatments: costs, benefits and decision-making procedures: editorial. South African Medical Journal, 93(6), p-433. | en_ZA |
| dc.identifier.issn | 0256-9574 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Benatar, S R AU - Fleischer, T E AB - One hallmark of modern medicine is the ever-rising cost of providing life-saving or life-extending treatments. Advances in medical care and the ability to improve the duration and quality of life, combined with the expectations of both doctors and patients that all new modalities of treatment developed will be implemented in everyday practice, are the major reasons for modern medicine’s becoming so expensive. In these circumstances resource allocation decisions need to be made and appropriate priority-setting processes developed. This challenge faces all societies but most agonisingly middle income countries like South Africa where the expectations of physicians and patients are geared to the best that can be achieved in any country — even the wealthiest. Expensive, new or established standard treatments that may benefit patients may be considered in at least two categories. The first is when each individual patient will be a direct beneficiary. This applies, for example, when a pacemaker or orthopaedic prosthesis is installed, when an organ such as a kidney, heart or liver is transplanted, or when chronic renal dialysis is initiated. While such treatments have some mortality and a measure of sub-optimal results, good outcomes are the rule DA - 2003 DB - OpenUCT DP - University of Cape Town J1 - South African Medical Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2003 SM - 0256-9574 T1 - New treatments: Costs, benefits and decision-making procedures TI - New treatments: Costs, benefits and decision-making procedures UR - http://hdl.handle.net/11427/16211 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/16211 | |
| dc.identifier.vancouvercitation | Benatar SR, Fleischer TE. New treatments: Costs, benefits and decision-making procedures. South African Medical Journal. 2003; http://hdl.handle.net/11427/16211. | en_ZA |
| dc.language | eng | en_ZA |
| dc.publisher | Health and Medical Publishing Group | en_ZA |
| dc.publisher.department | Centre for Bioethics | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | Creative Commons Attribution - Noncommercial 3.0 Unported Works License (CC BY-NC 3.0) | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/ | en_ZA |
| dc.source | South African Medical Journal | en_ZA |
| dc.source.uri | http://www.samj.org.za/ | |
| dc.title | New treatments: Costs, benefits and decision-making procedures | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |